RAINRain Oncology Inc.

Nasdaq rainthera.com


$ 1.23 $ -0.02 (-1.63 %)    

Thursday, 25-Jan-2024 15:26:58 EST
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.21
$ 1.24
$ 0.00 x 0
$ 0.00 x 0
$ 1.22 - $ 1.24
$ 0.82 - $ 11.32
3,706,028
na
44.01M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-09-2023 09-30-2023 10-Q
2 08-10-2023 06-30-2023 10-Q
3 05-11-2023 03-31-2023 10-Q
4 03-09-2023 12-31-2022 10-K
5 11-10-2022 09-30-2022 10-Q
6 08-04-2022 06-30-2022 10-Q
7 05-04-2022 03-31-2022 10-Q
8 03-03-2022 12-31-2021 10-K
9 11-10-2021 09-30-2021 10-Q
10 08-10-2021 06-30-2021 10-Q
11 05-25-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rain-oncology-says-pursuant-to-proposed-deal-with-pathos-ai-15-demand-letters-have-been-sent-to-co-by-purported-co-stockholders-denies-all-allegations-in-demand-letters-sent-by-purported-company-stockholders

-SEC 8K Filing

 rain-oncology-goes-private-just-two-years-after-120m-nasdaq-debut

Rain Oncology Inc (NASDAQ: RAIN) has agreed to be acquired by Pathos AI Inc.

 reported-earlier-rain-oncology-to-be-acquired-by-pathos-ai-for-116share-plus-additional-contingent-value-rights

Pursuant and subject to the terms of the merger agreement, a subsidiary of Pathos will commence a tender offer to acquire all o...

 rain-oncology-q3-eps-019-beats-027-estimate

Rain Oncology (NASDAQ:RAIN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27)...

 rain-oncology-and-3-other-stocks-under-1-insiders-are-buying

The Dow Jones closed slightly higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern...

 rain-oncology-confirms-receipt-of-unsolicited-proposal-from-concentra-biosciences-to-acquire-all-outstanding-shares-of-stock-for-125share-in-cash-plus-a-cvr-representing-the-right-to-receive-80-of-net-proceeds-payable-from-any-license-or-disposition

Rain Oncology, Inc. (NASDAQ:RAIN) ("Rain") confirmed that it has received an unsolicited proposal from Tang Capital, LP...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 citigroup-maintains-neutral-on-rain-oncology-lowers-price-target-to-1

Citigroup analyst Yigal Nochomovitz maintains Rain Oncology (NASDAQ:RAIN) with a Neutral and lowers the price target from $1...

 stocks-that-hit-52-week-lows-on-monday

  Monday's session saw 175 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 283 companies set new 52-week lows.

 rain-oncology-q2-eps-061-misses-051-estimate

Rain Oncology (NASDAQ:RAIN) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.5...

 earnings-scheduled-for-august-10-2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

 10-short-squeeze-stocks-to-watch-aeglea-biotherapeutics-toro-corp-airsculpt-a-company-moves-up-4166-positions--more

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for th...

 mizuho-downgrades-rain-oncology-to-neutral-lowers-price-target-to-1

Mizuho analyst Graig Suvannavejh downgrades Rain Oncology (NASDAQ:RAIN) from Buy to Neutral and lowers the price target from...

 why-guidewire-software-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-bin...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION